Vesigen Therapeutics

Bayer helps Harvard spinout Vesigen to $28.5M series A
Fierce Biotech
Wed, 07/22/20 - 10:39 am
Bayer
Vesigen Therapeutics
Harvard
RNAi
MRNA
CRISPR